Published in
Elsevier, Journal of the American College of Cardiology, 1(63), p. 86-88, 2014
DOI: 10.1016/j.jacc.2013.07.050
Links
Tools
Effect of Treatment for 12 Weeks With Rilapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, on Arterial Inflammation as Assessed With 18F-Fluorodeoxyglucose-Positron Emission Tomography Imaging
Journal article published in 2013 by
Ahmed Tawakol,
Parmanand Singh,
James H. F. Rudd 
,
Joseph Soffer,
Gengqian Cai,
Esad Vucic,
Sarah P. Brannan,
Elizabeth A. Tarka,
Bonnie C. Shaddinger,
Lea Sarov-Blat,
Paul Matthews ,
Sharath Subramanian,
Michael Farkouh,
Zahi A. Fayad
,
Joseph Soffer,
Gengqian Cai,
Esad Vucic,
Sarah P. Brannan,
Elizabeth A. Tarka,
Bonnie C. Shaddinger,
Lea Sarov-Blat,
Paul Matthews ,
Sharath Subramanian,
Michael Farkouh,
Zahi A. Fayad
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 